Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lutai Danshen Baishao (鹿胎丹参白芍颗粒) is a traditional Chinese medicine health product formulated as granules. It is primarily marketed for the improvement of chloasma (melasma), especially in adult women. The formulation contains ingredients such as deer placenta (lutai), Salvia miltiorrhiza (danshen), and Paeonia lactiflora (baishao/white peony root). Additional active components include soy isoflavones, daidzin, daidzein, genistein, and genistin. The mechanism of action is based on traditional Chinese medicine principles—nourishing blood and regulating menstruation—with modern research suggesting possible antioxidant and estrogenic effects due to its phytoestrogen content. It does not have an established pharmaceutical mechanism or target but acts as a functional food supplement for skin pigmentation disorders[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lutai danshen baishao.